Cartesian Therapeutics (RNAC) announced the granting of inducement awards to two new employees. On January 2, the Company issued to these ...
Timothy C Barabe, Director at Cartesian Therapeutics RNAC, reported a large exercise of company stock options on November 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S ...
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback